Clinical trial
The Alpha-1 Foundation's and University of Florida's Alpha-1 Coded Testing (ACT)…
NCT00500123 · University of Florida, Other · Recruiting
Key facts
| NCT number | NCT00500123 |
|---|---|
| Title | The Alpha-1 Foundation's and University of Florida's Alpha-1 Coded Testing (ACT) Study |
| Official title | The Alpha-1 Foundation's and University of Florida's Alpha-1 Coded Testing (ACT) Study |
| Acronym | ACT |
| Lead sponsor | University of Florida, Other |
| Status | Recruiting |
| Study type | Observational [Patient Registry] |
| Conditions | Alpha-1 Antitrypsin Deficiency |
| Intervention type | Procedure |
| Interventions | Alpha-1 Antitrypsin Genotype |
| Enrollment | 50,000 |
| Start date | Jan 1, 2001 |
| Primary completion | Jan 1, 2050 |
| Completion | Jan 1, 2050 |
| First posted | Jul 12, 2007 |
| Last update posted | Nov 24, 2025 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: